Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis.

Ainhize Maruri-Aransolo Juan de Dios CaballeroMalkoa MichelenaMaría José Medina-PascualGema CarrascoOscar AsensioMaria ColsRafael Cantónnull null

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)

CHROMagar™ B. cepacia agar proved to have a very good sensitivity and specificity for the detection of clinical BCCs. Moreover, the chromogenic nature of the medium allowed us to clearly differentiate BCC from other Gram-negative species, filamentous fungi and yeasts, thereby facilitating the identification of contaminants.

Keyphrases

gram negative
multidrug resistant
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
loop mediated isothermal amplification
label free
mycobacterium tuberculosis
peritoneal dialysis
real time pcr
pulmonary tuberculosis
saccharomyces cerevisiae